FFCP PHASE1:Mm9::chr11:101178231..101178241,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=19192|HGNC=|MCL_coexpression_id=0|UniProt=A2A4J1|association_with_transcript=-49bp_to_ENSMUST00000151385_5end|description=CAGE_peak_8_at_Psme3_5end|id=chr11:101178231..101178241,+|ontology_enrichment_celltype=CL:0000893!1.08e-08!6;CL:0002489!1.08e-08!6;CL:0000898!1.08e-08!6;CL:0000809!1.08e-08!6;CL:0000810!1.08e-08!6;CL:0000895!1.08e-08!6;CL:0000808!1.08e-08!6;CL:0000894!1.08e-08!6;CL:0000806!1.08e-08!6;CL:0000807!1.08e-08!6;CL:0000805!1.08e-08!6;CL:0002425!1.08e-08!6;CL:0002436!1.08e-08!6;CL:0002427!1.08e-08!6;CL:0002428!1.08e-08!6;CL:0002429!1.08e-08!6;CL:0002433!1.08e-08!6;CL:0002431!1.08e-08!6;CL:0002432!1.08e-08!6|ontology_enrichment_celltype_v019_2=|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=|ontology_enrichment_uberon_v019_2=UBERON:0000473,2.16e-09,14;UBERON:0003135,7.70e-09,15;UBERON:0003101,2.35e-08,16;UBERON:0000079,2.35e-08,16;UBERON:0004176,6.30e-08,17;UBERON:0009196,6.30e-08,17;UBERON:0009117,6.30e-08,17;UBERON:0000991,1.52e-07,18;UBERON:0005564,1.52e-07,18|phase1_expression=0,0,0,0,0,0,0,0,0,0.234064526321993,0.171217968225505,0.0797721589953364,0,0,0.333109761815663,0,0,0.157731082679119,0,0,4.16712121740242,0,0,0,0,0,0.86152399231815,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.280888840263504,0,0,0,0,0,0,0,0,0,0,0.22836775943812,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.147610147979602,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.283076530788832,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.138199973804424,0,0,0,0,0,0,0,0,0,0,0,17.4744810992099,0,0,0,0,0,0,0,0,0,3.45636007509439,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.147198920134397,0,0,0,0,0,0,0,0,0,0,0,0,0,0.154936841185966,0,0,0,0,0,0,0|short_description=p8@Psme3}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=entrezgene:19192 | |||
|HGNC= | |||
|MCL_coexpression_id=0 | |||
|TSSclassifier=NA | |||
|UniProt=uniprot:A2A4J1 | |||
|association_with_transcript=-49bp_to_ENSMUST00000151385_5end | |||
|cluster_id=chr11:101178231..101178241,+ | |||
|description=CAGE_peak_8_at_Psme3_5end | |||
|id=chr11:101178231..101178241,+ | |||
|ontology_enrichment_celltype=CL:0000893!1.08e-08!6;CL:0002489!1.08e-08!6;CL:0000898!1.08e-08!6;CL:0000809!1.08e-08!6;CL:0000810!1.08e-08!6;CL:0000895!1.08e-08!6;CL:0000808!1.08e-08!6;CL:0000894!1.08e-08!6;CL:0000806!1.08e-08!6;CL:0000807!1.08e-08!6;CL:0000805!1.08e-08!6;CL:0002425!1.08e-08!6;CL:0002436!1.08e-08!6;CL:0002427!1.08e-08!6;CL:0002428!1.08e-08!6;CL:0002429!1.08e-08!6;CL:0002433!1.08e-08!6;CL:0002431!1.08e-08!6;CL:0002432!1.08e-08!6 | |||
|ontology_enrichment_celltype_v019_2= | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon= | |||
|ontology_enrichment_uberon_v019_2=UBERON:0000473,2.16e-09,14;UBERON:0003135,7.70e-09,15;UBERON:0003101,2.35e-08,16;UBERON:0000079,2.35e-08,16;UBERON:0004176,6.30e-08,17;UBERON:0009196,6.30e-08,17;UBERON:0009117,6.30e-08,17;UBERON:0000991,1.52e-07,18;UBERON:0005564,1.52e-07,18 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0.234064526321993,0.171217968225505,0.0797721589953364,0,0,0.333109761815663,0,0,0.157731082679119,0,0,4.16712121740242,0,0,0,0,0,0.86152399231815,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.280888840263504,0,0,0,0,0,0,0,0,0,0,0.22836775943812,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.147610147979602,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.283076530788832,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.138199973804424,0,0,0,0,0,0,0,0,0,0,0,17.4744810992099,0,0,0,0,0,0,0,0,0,3.45636007509439,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.147198920134397,0,0,0,0,0,0,0,0,0,0,0,0,0,0.154936841185966,0,0,0,0,0,0,0 | |||
|short_description=p8@Psme3 | |||
}} |
Revision as of 04:17, 5 August 2015
Short description: | p8@Psme3 |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_8_at_Psme3_5end |
Coexpression cluster: | MCL_coexpression_mm9:0 |
Association with transcript: | -49bp_to_ENSMUST00000151385_5end |
EntrezGene: | 19192 |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
testis | 2.16e-09 | 14 |
male reproductive organ | 7.70e-09 | 15 |
male organism | 2.35e-08 | 16 |
male reproductive system | 2.35e-08 | 16 |
external genitalia | 6.30e-08 | 17 |
indifferent external genitalia | 6.30e-08 | 17 |
indifferent gonad | 6.30e-08 | 17 |
gonad | 1.52e-07 | 18 |
gonad primordium | 1.52e-07 | 18 |